Abstract PR04: DNA-PK inhibition resensitizes ovarian cancer cells to cisplatin in vivo and is associated with modulation of AKT pathway signaling (2013)
Attributed to:
Confidence in Concept 2012 - Imperial
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ovca13-pr04
Publication URI: http://dx.doi.org/10.1158/1078-0432.ovca13-pr04
Type: Journal Article/Review
Parent Publication: Clinical Cancer Research
Issue: 19_Supplement